Skip to main content

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Aplastic Anemia: A Phase I/II Trial with Emphasis on Very Severe Neutropenia and Active Infection

  • Conference paper
Cytokines in Hemopoiesis, Oncology, and AIDS II

Abstract

Acquired aplastic anemia (AA) is defined as a syndrome in which pancytopenia is accompanied by marrow hypocellularity. The severity of AA, in terms of the 1979 International Aplastic Anemia Study Group guidelines [1], has prognostic significance. An extremely useful recent addition to these criteria is the definition of very severe aplastic anemia (VSAA) by the European Bone Marrow Transplant Group's Severe Aplastic Anemia Working Party [2]. While the prognosis in patients with AA has been improved with refinement of bone marrow transplantation [2] and immunosuppression [3], patients with VSAA, particularly when combined with infection, still have a poor prognosis. The availability of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) has enabled the start of numerous trails to investigate the therapeutic value of rhGM-CSF in AA [4–11]. The majority of patients included in these trials did not fulfill the criteria of VSAA, i.e., they had significant residual myelopoiesis. With one exception [5] they were free of infections when entering the study.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R (1979) A prospective study of androgens and bone marrow transplantation for aplastic anemia. Blood 53: 504 – 514

    PubMed  CAS  Google Scholar 

  2. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, van Lint MR, Congiu M, De Planque MM, Ernst P, Mc Cann S, Raghavachar A, Frickhofen N, Würsch A, Marmont AM, Gordon-Smith EC (1988) Bone marrow transplantation versus immunosuppression for the treatment of severe aplastic anemia. Br J Haematol 70: 177 – 182

    Article  PubMed  CAS  Google Scholar 

  3. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meuseres P, Salama A, Heimpel H (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324: 1297 – 1304

    Article  PubMed  CAS  Google Scholar 

  4. Antin JH, Smith BR, Holmes W, Rosenthal DS (1988) Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72: 705 – 713

    PubMed  CAS  Google Scholar 

  5. Nissen C, Tichelli A, Gratwohl A, Speck B, Milne A, Gordon-Smith EC, Schaedelin J (1988) Failure of recombinant human granulocyte-macrophage colony stimulating factor therapy in aplastic anemia patients with very severe neutropenia. Blood 72: 2045 – 2047

    PubMed  CAS  Google Scholar 

  6. Vadhan-Raj S, Buescher S, Le Maistre A, Keating M, Walters R, Ventura C, Hittelman W, Broxmeyer HE, Gutterman JH (1988) Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 72: 134 – 141

    PubMed  CAS  Google Scholar 

  7. Vadhan-Raj S, Buescher S, Broxmeyer HE, Le Maistre A, Lepe-Zumiga JL, Ventura G, Jeka S, Horwitz LJ, Trujillo JM, Gillis S, Hittelman WN, Gutterman JU (1988) Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 319: 1628 – 1634

    Article  PubMed  CAS  Google Scholar 

  8. Champlin RE, Nimer SD, Ireland P, Oette DH, Golde DW (1989) Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony stimulating factor. Blood 73: 694 – 699

    PubMed  CAS  Google Scholar 

  9. Hinterberger W, Hoffmann S, Bettelheim P, Geißler K, Maurer D, Muhen M (1989) The use of growth factors in severe aplastic anemia. Bone Marrow Transplant 4 (Suppl 4): 129 – 130

    PubMed  Google Scholar 

  10. Guinan EC, Sieff CA, Oette DH, Nathan DG (1990) A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 76: 1077 – 1082

    PubMed  CAS  Google Scholar 

  11. Schuster MW, Lin ET, Solberg LA, Stadtmauer E, Bennett JM, Israel RJ (1990) Granulocyte-macrophage colony-stimulating factor (GM-CSF) for aplastic anemia: preliminary results of a multicenter randomized controlled trial. Blood 76 (Suppl 1): 47a

    Google Scholar 

  12. Herrmann F, Lindemann A, Raghavachar A, Heimpel H, Mertelsmann R (1990) In vivo recruitment of GM-CSF responsive myelopoietic progenitor cells by interleukin-3 in aplastic anemia. Leukemia 4: 671 – 672

    PubMed  CAS  Google Scholar 

  13. Takahashi M, Nikkuni K, Moriyama Y, Shibata A (1991) GM-CSF mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol. Am J Hematol 36: 213 – 214

    Article  PubMed  CAS  Google Scholar 

  14. Kaczmarski RS, Mufti GJ (1990) Hypoalbuminemia after prolonged treatment with recombinant granulocyte-macrophage colony-stimulating factor. Br Med J 301: 1312 – 1313

    CAS  Google Scholar 

  15. Emminger W, Emminger-Schmidmeier W, Peters C, Susani M, Hawliczek R, Höcker P, Gadner H (1990) Capillary leak syndrome during low dose granulocyte macrophage colony-stimulating factor (rhGM-CSF) treatment of a patient in a continuous febrile state. Blut 61: 219 – 221

    Article  PubMed  CAS  Google Scholar 

  16. Arming M, Kliche KO, Schneider W (1991) GM-CSF therapy and capillary-leak syndrome (letter). Ann Hematol 62: 83

    Article  Google Scholar 

  17. Kojima S, Fukuda M, Miyajima Y, Matsuyama T, Horibe K (1991) Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood 77: 937 – 941

    PubMed  CAS  Google Scholar 

  18. Potter MN, Mott MG, Oakhill A (1990) The successful treatment of a case of very severe aplastic anemia with granulocyte-macrophage colony-stimulating factor and antilymphocyte globulins. Br J Haematol 75: 618 – 619

    Article  PubMed  CAS  Google Scholar 

  19. Kojima S, Fukuda M, Miyajima Y, Matsuyama T (1990) Cyclosporine and recombinant granulocyte colony-stimulating factor in severe aplastic anemia. N Engl J Med 323: 920 – 921

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag, Berlin Heidelberg

About this paper

Cite this paper

Raghavachar, A. et al. (1992). Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Aplastic Anemia: A Phase I/II Trial with Emphasis on Very Severe Neutropenia and Active Infection. In: Freund, M., Link, H., Schmidt, R.E., Welte, K. (eds) Cytokines in Hemopoiesis, Oncology, and AIDS II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48715-6_69

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-48715-6_69

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55242-0

  • Online ISBN: 978-3-642-48715-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics